X-102715051-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004051.4(GPRASP2):c.182G>A(p.Arg61Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000561 in 1,211,648 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 3AN: 113448Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35590
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183348Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67810
GnomAD4 exome AF: 0.0000592 AC: 65AN: 1098200Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 18AN XY: 363586
GnomAD4 genome AF: 0.0000264 AC: 3AN: 113448Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35590
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.182G>A (p.R61K) alteration is located in exon 5 (coding exon 1) of the GPRASP2 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at